Allergan PLC closed the acquisition of Envy Medical Inc., a personal and beauty products company that develops and markets skin treatments for both dermatologic or aesthetic conditions.
With the completion of this acquisition, Dublin-based Allergan has added the dermalinfusion skin treatment system to its portfolio.
Dermalinfusion in a noninvasive process used to treat a number of skin conditions. It works by simultaneously removing damaged cells, delivering specific serums and clearing the surface and pores of the skin.
Long Beach, Calif.-based Envy Medical's proprietary skin care products that will expand Allergan's SkinMedica portfolio.
Allergan did not disclose the financial details of the transaction.